论文部分内容阅读
目的:评价综合介入(肝动脉化疗栓塞联合超声引导下介入)治疗不能手术切除的原发肝癌的疗效。方法:62例不能手术切除的原发肝癌患者分为两组,A组31例行单纯TACE,B组31例行综合介入治疗,于TACE治疗两周后再行超声引导下介入治疗。结果:本组病例全部随访1个月～2年。B组1年、2年的生存率分别为58.06%和38.71%,高于A组的22.58%和9.685(均P<0.01)。结论:对于不能手术切除的肝细胞癌,综合介入治疗的疗效明显优于单纯TACE。
Objective: To evaluate the efficacy of comprehensive intervention (hepatic arterial chemoembolization combined with ultrasound guided interventional therapy) in the treatment of unresectable primary liver cancer. Methods: Totally 62 patients with unresectable primary liver cancer were divided into two groups: 31 patients in group A received TACE alone, and 31 patients in group B received comprehensive interventional therapy. After TACE treatment for two weeks, they were treated with ultrasound guided intervention. Results: All cases were followed up for 1 month to 2 years. The 1-year and 2-year survival rates in group B were 58.06% and 38.71%, respectively, which were higher than those in group A (22.58% and 9.685, all P <0.01). Conclusion: The curative effect of comprehensive interventional therapy is obviously better than that of simple TACE for unresectable hepatocellular carcinoma.